NO980211L - Opplösning av 1-azabicyklo£2,2,2|oktan-3-amin, 2-(difenylmetyl)-N-££2-metoksy-5-(1-metyletyl)fenyl|metyl| - Google Patents

Opplösning av 1-azabicyklo£2,2,2|oktan-3-amin, 2-(difenylmetyl)-N-££2-metoksy-5-(1-metyletyl)fenyl|metyl|

Info

Publication number
NO980211L
NO980211L NO980211A NO980211A NO980211L NO 980211 L NO980211 L NO 980211L NO 980211 A NO980211 A NO 980211A NO 980211 A NO980211 A NO 980211A NO 980211 L NO980211 L NO 980211L
Authority
NO
Norway
Prior art keywords
methyl
diphenylmethyl
azabicyclo
methoxy
amine
Prior art date
Application number
NO980211A
Other languages
English (en)
Norwegian (no)
Other versions
NO980211D0 (no
Inventor
Derek L Tickner
Morgan Meltz
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO980211D0 publication Critical patent/NO980211D0/no
Publication of NO980211L publication Critical patent/NO980211L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
NO980211A 1995-07-17 1998-01-16 Opplösning av 1-azabicyklo£2,2,2|oktan-3-amin, 2-(difenylmetyl)-N-££2-metoksy-5-(1-metyletyl)fenyl|metyl| NO980211L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US119195P 1995-07-17 1995-07-17
PCT/IB1996/000648 WO1997003984A1 (en) 1995-07-17 1996-07-04 Resolution of 1-azabicyclo[2.2.2]octan-3-amine, 2-(diphenylmethyl)-n-[[2-methoxy-5-(1-methylethyl)phenyl]methyl]

Publications (2)

Publication Number Publication Date
NO980211D0 NO980211D0 (no) 1998-01-16
NO980211L true NO980211L (no) 1998-03-16

Family

ID=21694832

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980211A NO980211L (no) 1995-07-17 1998-01-16 Opplösning av 1-azabicyklo£2,2,2|oktan-3-amin, 2-(difenylmetyl)-N-££2-metoksy-5-(1-metyletyl)fenyl|metyl|

Country Status (26)

Country Link
US (1) US6008357A (es)
EP (1) EP0840735B1 (es)
JP (1) JP3043074B2 (es)
KR (1) KR100276989B1 (es)
CN (1) CN1068598C (es)
AR (1) AR002772A1 (es)
AT (1) ATE250600T1 (es)
AU (1) AU697553B2 (es)
CA (1) CA2227194C (es)
CO (1) CO4480720A1 (es)
CZ (1) CZ15098A3 (es)
DE (1) DE69630123T2 (es)
DK (1) DK0840735T3 (es)
ES (1) ES2205039T3 (es)
HK (1) HK1010195A1 (es)
HU (1) HUP9900238A3 (es)
IL (1) IL122655A0 (es)
MY (1) MY115734A (es)
NO (1) NO980211L (es)
NZ (1) NZ310539A (es)
PE (1) PE8798A1 (es)
PL (1) PL184261B1 (es)
PT (1) PT840735E (es)
RU (1) RU2136681C1 (es)
WO (1) WO1997003984A1 (es)
ZA (1) ZA966026B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861526B2 (en) * 2002-10-16 2005-03-01 Pfizer Inc. Process for the preparation of (S,S)-cis-2-benzhydryl-3-benzylaminoquinuclidine
AU2005210259A1 (en) * 2004-02-02 2005-08-18 Pfizer Products Inc. Process for preparation of 1-(2S,3S)-2-benzhydr yl-N-(5-tert-butyl-2-methoxybenzyl)quinuclidin-3-amine
JP2008519837A (ja) * 2004-11-10 2008-06-12 ベーリンガー インゲルハイム ケミカルズ インコーポレイテッド フェンタニル中間体の生成方法
CN102395557A (zh) * 2008-12-09 2012-03-28 佛罗里达大学研究基金会公司 激酶抑制剂化合物
US20160332962A1 (en) 2015-05-13 2016-11-17 Janssen Pharmaceutica Nv (s)-csa salt of s-ketamine, (r)-csa salt of s-ketamine and processes for the preparation of s-ketamine
CN108341812A (zh) * 2017-01-23 2018-07-31 科贝源(北京)生物医药科技有限公司 一种含奎宁环化合物的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX18467A (es) * 1988-11-23 1993-07-01 Pfizer Agentes terapeuticos de quinuclidinas
NO168529C (no) * 1989-09-15 1992-03-04 Chiron Lab As Fremgangsmaate for fremstilling av s-(-) og r-(+)-n-(quinuclidinyl-3)-amider.
DK0585328T3 (da) * 1991-05-22 2002-02-11 Pfizer Substituerede 3-aminoquinuclidiner
RU2103269C1 (ru) * 1991-05-31 1998-01-27 Пфайзер Инк. Производные хинуклидина или их фармацевтически приемлемые соли и фармацевтическая композиция
US5604241A (en) * 1992-10-21 1997-02-18 Pfizer Inc. Substituted benzylaminoquinuclidines as substance P antagonists

Also Published As

Publication number Publication date
PL324610A1 (en) 1998-06-08
US6008357A (en) 1999-12-28
CA2227194C (en) 2002-02-12
AU697553B2 (en) 1998-10-08
HUP9900238A2 (hu) 1999-05-28
CA2227194A1 (en) 1997-02-06
AU6134896A (en) 1997-02-18
RU2136681C1 (ru) 1999-09-10
CZ15098A3 (cs) 1999-02-17
AR002772A1 (es) 1998-04-29
CN1068598C (zh) 2001-07-18
EP0840735A1 (en) 1998-05-13
CN1190970A (zh) 1998-08-19
JP3043074B2 (ja) 2000-05-22
WO1997003984A1 (en) 1997-02-06
KR19990029058A (ko) 1999-04-15
HUP9900238A3 (en) 2001-08-28
DE69630123D1 (en) 2003-10-30
JPH10511102A (ja) 1998-10-27
NZ310539A (en) 1998-11-25
ES2205039T3 (es) 2004-05-01
PT840735E (pt) 2004-02-27
NO980211D0 (no) 1998-01-16
PL184261B1 (pl) 2002-09-30
MX9800538A (es) 1998-05-31
MY115734A (en) 2003-08-30
ATE250600T1 (de) 2003-10-15
DE69630123T2 (de) 2004-04-08
IL122655A0 (en) 1998-08-16
HK1010195A1 (en) 1999-06-17
DK0840735T3 (da) 2004-02-09
EP0840735B1 (en) 2003-09-24
PE8798A1 (es) 1998-03-02
CO4480720A1 (es) 1997-07-09
ZA966026B (en) 1998-01-16
KR100276989B1 (ko) 2001-01-15

Similar Documents

Publication Publication Date Title
LU92132I2 (fr) Sel d'aclidinium avec anion d'un acide mono ou polyvalent pharmaceutiquement acceptable particulièrement le bromure d'aclidinium
CA2024572A1 (en) N-substituted-4-pyrimidinamines and-pyrimidinediamines, a process for their preparation and their use as medicaments
KR900018087A (ko) 옥사디아졸 및 이의염, 치매를 치료하기 위한 이의 용도, 이의 제조방법 및 제제
KR880002834A (ko) α-알킬-4-아미노-3-퀴놀린메탄올 및 1-(4-아르알킬아미노-3-퀴놀리닐) 알칸온, 이의 제조방법 및 약제로서의 용도
WO2003070731A3 (en) Azabicyclic compounds for the treatment of disease
Calaza et al. Stereoselective synthesis of quaternary proline analogues
AU8111798A (en) Resolution of amines
NO980211L (no) Opplösning av 1-azabicyklo£2,2,2|oktan-3-amin, 2-(difenylmetyl)-N-££2-metoksy-5-(1-metyletyl)fenyl|metyl|
NO903389L (no) Fremgangsmaate for fremstilling av 1,3-dihydro-1-(pyridinylamino)-2h-indol-2-oner, samt anvendelse som medikamenter.
ATE262510T1 (de) Auflösung von ritalinsäure-salz
EA200000057A1 (ru) (+)-норцисаприд, пригодный для лечения нарушений, опосредованных 5-нт3 и 5-нт4 (рецепторами)
Couty et al. 2‐Cyanoazetidines and Azetidinium Ions: Scaffolds for Molecular Diversity
NO20013941D0 (no) Polynukleotider med forkortet kjede og fremgangsmate ved fremstillingen derav
DE3875953D1 (de) Verfahren zur herstellung von organischen chemischen verbindungen.
KR910004597A (ko) 1-(피리디닐아미노)-2-피롤리디논, 이의 제조방법 및 약제로서의 이의 용도
KR910004598A (ko) 2,3-디하이드로-1-(피리디닐아미노)-인돌, 이의 제조방법 및 약제로서 이의 용도
ATE46341T1 (de) Verfahren zur herstellung von optisch aktivem 1benzyl-3,4-bis-(diphenylphosphino)-pyrrolidin.
ES2145260T3 (es) Mejoras introducidas en sintesis quirales.
BR0313246A (pt) Processo de preparação de fenilamida do ácido 5-(4-fluorfenil)-1-[2-((2r,4r)-4-hidróxi-6-oxo-tetrahidr o-piran-2-il)etil]-2-isopropil-4-fenil-1h-pirrol-3-carbo xìlico
ATE60788T1 (de) Derivat von p-aminophenol mit mucrosekretolytischer fluessiger und antipyretischer wirksamkeit, dessen verfahren zur herstellung und dessen pharmazeutische zusammensetzungen.
BR0008586A (pt) Processo de preparação de aminoácidos quirais e processo de preparação de compostos a partir destes
HUP0004432A2 (hu) (R)-3-{[(4-Fluorfenil)szulfonil]amino}-1,2,3,4-tetrahidro-9H-karbazol-9-propánsav (ramatroban) termodinamikailag stabil formája és a vegyületet tartalmazó gyógyászati készítmény
DE69418353D1 (de) Cyclische Pentapeptide mit Beta-Turn und Gamma-Turn
ATE301637T1 (de) Verfahren zur herstellung von n-geschützten azetidin-2-carbonsäuren
PT94298A (pt) Processo para a preparacao de derivados de 4, 5, 5a, 6-tetra-hidro-3h-isoxazolo{5,4,3-k1}acridinas e de composicoes farmaceuticas que os contem

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application